A Case of Concurrent Psoriasis and Hidradenitis Suppurativa Successfully Treated with Tildrakizumab
Crossref DOI link: https://doi.org/10.1007/s13555-023-00940-0
Published Online: 2023-06-02
Published Print: 2023-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Damsin, Thomas
Funding for this research was provided by:
Almirall R&D, Barcelona, Spain
Text and Data Mining valid from 2023-06-02
Version of Record valid from 2023-06-02
Article History
Received: 11 April 2023
Accepted: 11 May 2023
First Online: 2 June 2023